ALVESCO

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug ALVESCO contains one active pharmaceutical ingredient (API):

1 Ciclesonide UNII S59502J185 - CICLESONIDE

Ciclesonide exhibits low binding affinity to the glucocorticoid-receptor. Once orally inhaled, ciclesonide is enzymatically converted in the lungs to the principal metabolite (C21-des-methylpropionyl-ciclesonide) which has a pronounced anti-inflammatory activity and is thus considered as the active metabolite. Read about Ciclesonide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALVESCO 80 Pressurised inhalation, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BA08	Ciclesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8853Y, 8854B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501103801170316, 501103901175311
Country: CA	Health Products and Food Branch	Identifier(s): 02285606, 02285614
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02484858, 02787033, 02787091, 02787116, 03418935, 03418958, 03736894, 03895463, 05909330, 06103882, 06103936, 06103942, 06562101, 06573837, 06934620, 06934790, 07717592, 07717600, 07753151, 08839587, 09156264, 09176019, 09202308, 10073193, 10298839, 10298845, 10301292, 10525956, 11647029, 12567976, 16060145, 16792894, 16812042, 16923445, 17204416
Country: EE	Ravimiamet	Identifier(s): 1156328, 1156339, 1156340, 1239577, 1239588, 1239599, 1239612, 1239623, 1322862, 1322873, 1322884, 1441987
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70372
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 032105, 032141, 032178, 032214
Country: FR	Base de données publique des médicaments	Identifier(s): 63599556, 66052179
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 180506, 299591, 299595, 375772, 377402, 90040, 90043, 93425
Country: HK	Department of Health Drug Office	Identifier(s): 53034, 53035
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-058422961
Country: IE	Health Products Regulatory Authority	Identifier(s): 11807, 11951
Country: JP	医薬品医療機器総合機構	Identifier(s): 2290702G1025, 2290702G2021, 2290702G3028, 2290702G4024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1016744, 1016745, 1016746, 1022811, 1022812, 1022813, 1022814, 1028368, 1033353, 1052058, 1052059
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 456M2004
Country: NL	Z-Index G-Standaard	Identifier(s): 15049159, 15049175
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 77674, 77690, 87041, 87939
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11092, 11093
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100133028, 100133034, 100463764
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67522001, W67522002, W67522003, W67523001, W67523002, W67523003
Country: SG	Health Sciences Authority	Identifier(s): 13233P, 13234P
Country: US	FDA, National Drug Code	Identifier(s): 70515-711, 70515-712
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/21.5.1/0530, 37/21.5.1/0531